Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations

Jennifer B Rosen1, Joel G Breman

  • 1Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. jennifer.rosen@uhmc.sunysb.edu

PubMed

Insights

Intermittent preventive treatment with amodiaquine (IPTi) in infants reduced malaria fevers. This malaria control strategy may improve vaccine responses in children, warranting further investigation.

Area of Science:

  • Global Health
  • Immunology
  • Pediatrics

Background:

  • Malaria causes millions of deaths annually, primarily in young children in sub-Saharan Africa.
  • Acute malaria is linked to diminished immune responses to essential childhood vaccines.
  • Antimalarial drugs, including 4-aminoquinolones, may potentially suppress vaccine immunity.

Purpose of the Study:

  • To investigate the impact of amodiaquine intermittent preventive treatment (IPTi) on malaria incidence in infants.
  • To assess the safety and efficacy of IPTi when co-administered with routine infant vaccinations.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 291 infants aged 12-16 weeks in Tanzania.
  • Infants received their third dose of combined diphtheria-tetanus-pertussis and poliomyelitis vaccines alongside IPTi or placebo.
  • Malaria fevers were monitored over a 60-day period.

Main Results:

  • Infants receiving amodiaquine IPTi experienced significantly fewer malaria fevers compared to the placebo group.
  • The study demonstrated a reduction in malaria burden in infants receiving IPTi.

Conclusions:

  • Co-administration of IPTi with routine infant immunizations is a viable strategy for malaria control.
  • Further research is warranted due to the increasing overlap of malaria control and vaccination efforts.
  • Increased travel to malaria-endemic regions necessitates understanding concurrent vaccination and chemoprophylaxis effects.
Abstract

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...